Skip to main content
Log in

Hyperreactivity of Platelets to Serotonin (5-Hydroxytryptamine) in Patients with Cardiovascular Diseases

Influence of Ketanserin, a Serotonin S2-Receptor Antagonist

  • Short Communication
  • Poster Presentations: The Role of Serotonin in Cardiovascular Diseases
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • De Clerck F, Van Nueten JM. Platelet-mediated vascular contractions: inhibition of the serotonergic component by ketanserin. Thrombosis Research 27: 713–723, 1982

    Article  PubMed  Google Scholar 

  • De Clerck F, David JL, Janssen PAJ. Serotonergic amplification mechanisms in blood platelets. In De Clerck F, Vanhoutte P (Eds) 5-Hydroxytryptamine in peripheral reactions, pp. 83–94, Raven Press, New York, 1982

    Google Scholar 

  • De Clerck F, Loots W, Jageneau A, Nevelsteen A. Correction by ketanserin of the platelet-mediated inhibition of peripheral collateral circulation in the cat. Measurement of blood flow with radioactive microspheres. Drug Development Research 8: 149–158, 1986

    Article  Google Scholar 

  • De Crée J, Geukens H, Leempoels J, Verhaegen H. Placebo-controlled double-blind trial in treatment of intermittent claudication. Lancet 2: 775–778, 1984

    Article  PubMed  Google Scholar 

  • De Crée J, Leempoels J, Demoen B, Roels V, Verhaegen H. The effect of ketanserin, a 5-HT2-receptor antagonist, on 5-hydroxytryptamine-induced irreversible platelet aggregation in patients with cardiovascular diseases. Agents and Actions 16: 313–317, 1985

    Article  PubMed  Google Scholar 

  • Dreyfuss F, Zahavi J. Adenosine diphosphate-induced platelet aggregation in myocardial infarction and ischemic heart disease. Atherosclerosis 17: 107–120, 1973

    Article  CAS  PubMed  Google Scholar 

  • Leysen JE, Awouters F, Kennis L, Laduron PM, Vandenberk J, et al. Receptor binding profile of R 41468, a novel antagonist on 5-HT2-receptors. Life Sciences 28: 1015–1022, 1981

    Article  CAS  PubMed  Google Scholar 

  • Mehta J. Platelets and prostaglandins in coronary artery disease. American Journal of Medicine 249: 2818–2823, 1983

    CAS  Google Scholar 

  • Schwartz MB, Haniger J, Timmons S, Friesinger GC. Platelet aggregates in ischemic heart disease. Thrombosis and Haemostasis 434: 185–188, 1980

    Google Scholar 

  • Vanhoutte P, Amery A, Birkenhäger W, Breckenridge A, Bühler F, et al. Serotonergic mechanisms in hypertension. Focus on the effects of ketanserin. Hypertension 11: 111–133, 1988

    Article  CAS  PubMed  Google Scholar 

  • Van Nueten JM, Janssen PAJ, Symoens J, Janssens WJ, Heykants J, et al. Ketanserin. In Scriabine A (Ed.) New cardiovascular drugs in 1987, pp. 1–55, Raven Press, New York, 1987

    Google Scholar 

  • White JC. A biphasic response of platelets to serotonin. Scandinavian Journal of Haematology 7: 145–151, 1970

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

De Crée, J., Roels, V. & Verhaegen, H. Hyperreactivity of Platelets to Serotonin (5-Hydroxytryptamine) in Patients with Cardiovascular Diseases. Drugs 36 (Suppl 1), 87–91 (1988). https://doi.org/10.2165/00003495-198800361-00015

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198800361-00015

Keywords

Navigation